Impression Healthcare (ASX:IHL)
- CEO:Joel Latham
Impression Healthcare (ASX:IHL) Stock Price
Impression Healthcare (ASX:IHL) Company Overview
Impression Healthcare (ASX:IHL) started life as a manufacturer and supplier of custom-fit mouthguards, and other dental equipment. The Oral devices business continues to show strong revenue growth from all products; including, sports mouthguards for teeth protection and to reduce concussion risk, and sophisticated devices made to combat sleep apnoea, snoring and bruxism.
The other side of the company is a rapidly expanding Medicinal cannabis business with four unique clinical trials in partnership with Swinburne University of Technology, that are complementary to the issues they currently aim to prevent with the range of oral devices.
IHL's cannabinoid drug discovery brand Incannex Pharmaceuticals is a collaboration with an EU-based cannabinoid drug design company named Linnea SA. The EU-based company will serve as IHL's supply partner for the base cannabinoid materials in four novel cannabinoid formulations.
IHL has also secured Australian licenses in place to import, export and distribute cannabis products and access to Cannvalate – the largest network of cannabis medicine prescribers in Australia.
- Address:13 Central Avenue, Moorabbin, VIC 3189, Australia
Impression Healthcare (ASX:IHL) Financials
The latest update from the companyClick Here
Stay updated about
Signup to get updates.
During this time, he played an instrumental role in the marketing and procurement of multiple revenue-generating opportunities and collaborations, including with Pacific Smiles, the NRL, AFL and the implementation of Gameday’s ambassadorial program.
He was previously employed by HSBC—where he acted as COO and Executive Director—as well as being the CFO and Company Secretary for Global Health Ltd.
Fowles also spent 17 years working with the boutique fund manager, Contango Asset Management Limited, where he took on a wide variety of roles, including executive director, COO and Company Secretary.
Valentine brings a broad range of experience and skills related to the management of ASX-listed emerging companies to his role as Chairman. Aside from his work with Impression Healthcare, Valentine is also the Executive Director of a boutique advisory firm, Alignment Capital Pty Ltd.
Agarwal received his medical qualifications in the United Kingdom before immigrating to Australia in 2001. He has since played a key role in the commercialisation, scaling and successfully exiting of three healthcare businesses.